Drugplain

Emtricitabine and tenofovir disoproxil fumarate 133 mg/1

Emtricitabine and tenofovir disoproxil fumarate · TABLET, FILM COATED · Zydus Lifesciences Limited

No Recall History
Plain English

Emtricitabine and tenofovir disoproxil fumarate is a combination medication used to treat HIV infection as part of antiretroviral therapy. This oral tablet contains two nucleoside reverse transcriptase inhibitors that work together to reduce HIV levels in the body.

Key Facts

Brand Name
Emtricitabine and tenofovir disoproxil fumarate
Generic Name
Emtricitabine and tenofovir disoproxil fumarate
NDC Code (Product)
70771-1621
Manufacturer
Zydus Lifesciences Limited
Strength
133 mg/1
Dosage Form
TABLET, FILM COATED
Route
ORAL
Marketing Status
Application #
ANDA212689
Drug Class
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
Marketing Start
07/01/2021

Recall History

No Recall History

Frequently Asked Questions

What is Emtricitabine and tenofovir disoproxil fumarate used for?

Emtricitabine and tenofovir disoproxil fumarate is a combination medication used to treat HIV infection as part of antiretroviral therapy. This oral tablet contains two nucleoside reverse transcriptase inhibitors that work together to reduce HIV levels in the body.

Is Emtricitabine and tenofovir disoproxil fumarate a controlled substance?

Emtricitabine and tenofovir disoproxil fumarate is not classified as a controlled substance by the DEA.

What is the generic name for Emtricitabine and tenofovir disoproxil fumarate?

The generic name for Emtricitabine and tenofovir disoproxil fumarate is Emtricitabine and tenofovir disoproxil fumarate. There are 8 other brand versions of Emtricitabine and tenofovir disoproxil fumarate.

What is the NDC code for Emtricitabine and tenofovir disoproxil fumarate 133 mg/1?

The NDC (National Drug Code) for Emtricitabine and tenofovir disoproxil fumarate 133 mg/1 is 70771-1621, listed by Zydus Lifesciences Limited.